These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38065313)

  • 1. Lipoamino bundle LNPs for efficient mRNA transfection of dendritic cells and macrophages show high spleen selectivity.
    Haase F; Pöhmerer J; Yazdi M; Grau M; Zeyn Y; Wilk U; Burghardt T; Höhn M; Hieber C; Bros M; Wagner E; Berger S
    Eur J Pharm Biopharm; 2024 Jan; 194():95-109. PubMed ID: 38065313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Endothelial Cell Gene Silencing by siRNA-LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting.
    Yazdi M; Pöhmerer J; Hasanzadeh Kafshgari M; Seidl J; Grau M; Höhn M; Vetter V; Hoch CC; Wollenberg B; Multhoff G; Bashiri Dezfouli A; Wagner E
    Small; 2024 Oct; 20(42):e2400643. PubMed ID: 38923700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating efficacy and cytotoxicity of lipoamino fatty acid nucleic acid carriers using disulfide or hydrophobic spacers.
    Steffens RC; Thalmayr S; Weidinger E; Seidl J; Folda P; Höhn M; Wagner E
    Nanoscale; 2024 Jul; 16(29):13988-14005. PubMed ID: 38984864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicomponent Synthesis of Imidazole-Based Ionizable Lipids for Highly Efficient and Spleen-Selective Messenger RNA Delivery.
    Dong W; Li Z; Hou T; Shen Y; Guo Z; Su YT; Chen Z; Pan H; Jiang W; Wang Y
    J Am Chem Soc; 2024 Jun; 146(22):15085-15095. PubMed ID: 38776232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose.
    Germer J; Lessl AL; Pöhmerer J; Grau M; Weidinger E; Höhn M; Yazdi M; Cappelluti MA; Lombardo A; Lächelt U; Wagner E
    J Control Release; 2024 Jun; 370():239-255. PubMed ID: 38663751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput
    Hamilton AG; Swingle KL; Thatte AS; Mukalel AJ; Safford HC; Billingsley MM; El-Mayta RD; Han X; Nachod BE; Joseph RA; Metzloff AE; Mitchell MJ
    ACS Nano; 2024 Jun; 18(25):16151-16165. PubMed ID: 38861479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
    Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
    J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Chameleon Carriers for Nucleic Acid Delivery: The Sweet Spot between Lipoplexes and Polyplexes.
    Thalmayr S; Grau M; Peng L; Pöhmerer J; Wilk U; Folda P; Yazdi M; Weidinger E; Burghardt T; Höhn M; Wagner E; Berger S
    Adv Mater; 2023 Jun; 35(25):e2211105. PubMed ID: 37001016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.
    Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esterase-Labile Quaternium Lipidoid Enabling Improved mRNA-LNP Stability and Spleen-Selective mRNA Transfection.
    Zhang R; Shao S; Piao Y; Xiang J; Wei X; Zhang Z; Zhou Z; Tang J; Qiu N; Xu X; Liu Y; Shen Y
    Adv Mater; 2023 Nov; 35(46):e2303614. PubMed ID: 37490011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorinated Lipid Nanoparticles for Enhancing mRNA Delivery Efficiency.
    Zhang H; Meng C; Yi X; Han J; Wang J; Liu F; Ling Q; Li H; Gu Z
    ACS Nano; 2024 Mar; 18(11):7825-7836. PubMed ID: 38452271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and lyophilization of mRNA-encapsulating lipid nanoparticles.
    Wang T; Yu T; Li W; Liu Q; Sung TC; Higuchi A
    Int J Pharm; 2024 Sep; 662():124514. PubMed ID: 39067550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy.
    Escalona-Rayo O; Zeng Y; Knol RA; Kock TJF; Aschmann D; Slütter B; Kros A
    Biomed Pharmacother; 2023 Sep; 165():115065. PubMed ID: 37406506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
    M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
    Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
    Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
    Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs.
    Tombácz I; Laczkó D; Shahnawaz H; Muramatsu H; Natesan A; Yadegari A; Papp TE; Alameh MG; Shuvaev V; Mui BL; Tam YK; Muzykantov V; Pardi N; Weissman D; Parhiz H
    Mol Ther; 2021 Nov; 29(11):3293-3304. PubMed ID: 34091054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the Fate of MP1000-LPX
    He S; Xia S; Song X; Huang H; Wang X; Jiang X; Jin Z
    Pharm Nanotechnol; 2020; 8(5):399-408. PubMed ID: 32895048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.